Diffuse astrocytic tumors harboring IDH mutations can be diagnosed as astrocytoma, IDH-mutant if there is loss of ATRX nuclear expression and/or diffuse p53 immunopositivity without the need for 1p/19q testing [30]. This evidence concerns the gene IDH2 and astrocytic tumor.